Answer
Patients using Koselugo (selumetinib) 5 mg granules in capsule for opening should be instructed not to remove the desiccant from the bottle or swallow it.
Sources for this answer
- Koselugo 5 mg granules in capsule for openingAstraZeneca UK Limited · emc · SmPC §6.6 Special precautions for disposal and other handling · Version 1Document updated
Sources checked